Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
They relied on marijuana to get through the day. But then days felt impossible without it - 2Overlooked infertility care should be part of national health services, says WHO
- 3Most loved Occasion Dish: What Makes Your Merry Table?
- 46 Popular Men's Aromas On the planet
- 5This Tiny Neon Frog Dwells in the Clouds
- From Certificate to Dollars: College Majors with Extraordinary Monetary Prizes
- What’s your chronotype? Knowing whether you’re a night owl or an early bird could help you do better on tests and avoid scams
- Online business Stages for Little Retailers
- Are IDF reservists properly armed during post-war operations?
- Holiday spots Well known With Americans In 2024
- New law puts familiar drinks, creams and gummies in legal limbo
- The Electric Bicycle Americans Can Confide in 2024
- How Would You Like to Deal with Your Funds?
- The Craft of Computerized Detox: Individual Trials
